These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1261164)

  • 1. Disposition of propoxyphene and propranolol in children.
    Wilson JT; Atwood GF; Shand DG
    Clin Pharmacol Ther; 1976 Mar; 19(3):264-70. PubMed ID: 1261164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.
    Olsen H; Aune H; Lilleaasen P; Gulliksen M; Bodd E; Mørland J
    Alcohol Clin Exp Res; 1986 Aug; 10(4):393-6. PubMed ID: 3530016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
    Bechgaard H; Baggesen S
    J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.
    Wolen RL; Ziege EA; Gruber CM
    Clin Pharmacol Ther; 1975 Jan; 17(1):15-20. PubMed ID: 1122667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): interindividual variation and influence of food intake.
    Melander A; Berlin-Wahlén A; Bodin NO; Danielson K; Gustafsson B; Lindgren S; Westerlund D
    Acta Med Scand; 1977; 202(1-2):119-24. PubMed ID: 899874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of ethanol on hepatic first-pass elimination of propoxyphene in rats.
    Oguma T; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):7-13. PubMed ID: 7288618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative bioavailability of a commercial propranolol hydrochloride tablet in man.
    Roscoe R; Cooper J; Wilson TW; Joshi NN; Midha KK
    Biopharm Drug Dispos; 1982; 3(2):105-14. PubMed ID: 7104460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propoxyphene and norpropoxyphene: influence of diet and fluid on plasma levels.
    Welling PG; Lyons LL; Tse FL; Craig WA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):559-65. PubMed ID: 1277712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propoxyphene and norpropoxyphene concentrations in blood and tissues in cases of fatal overdose.
    McBay AJ
    Clin Chem; 1976 Aug; 22(8):1319-21. PubMed ID: 949842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of propoxyphene and norpropoxyphene in man after a single oral dose.
    Verebely K; Inturrisi CE
    Clin Pharmacol Ther; 1974 Mar; 15(3):302-9. PubMed ID: 4815955
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.
    Girre C; Hirschhorn M; Bertaux L; Palombo S; Dellatolas F; Ngo R; Moreno M; Fournier PE
    Eur J Clin Pharmacol; 1991; 41(2):147-52. PubMed ID: 1743247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol interaction with propoxyphene and norpropoxyphene metabolism in isolated rat hepatocytes.
    Olsen H; Bodd E; Meyer T; Mørland J
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():301-4. PubMed ID: 6634844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of propoxyphene and norpropoxyphene in breast milk.
    Kunka RL; Venkataramanan R; Stern RM; Ladik CF
    Clin Pharmacol Ther; 1984 May; 35(5):675-80. PubMed ID: 6713779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.
    Giacomini KM; Giacomini JC; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Sep; 28(3):417-24. PubMed ID: 7408401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatographic determination of propoxyphene and norpropoxyphene in plasma.
    Cleemann M
    J Chromatogr; 1977 Feb; 132(2):287-94. PubMed ID: 833237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?
    Horsmans Y; Desager JP; Daenens C; Harvengt C; Geubel AP
    J Hepatol; 1994 Sep; 21(3):283-91. PubMed ID: 7836695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of propranolol and bendrofluazide formulations.
    McAinsh J; Holmes BF; Baber NS; Young J
    Biopharm Drug Dispos; 1981; 2(2):167-75. PubMed ID: 7248480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.